The data was analyzed on 2024-01-20.
Please visit https://forum.sickandabandoned.com/t/has-anybody-tried-heres-how-you-can-get-answers-to-that-question-fast/228
It is highly recommended that you start there.
The rankings section should give a rough idea as to which treatments stand out as being promising treatments.
The section ranks all of the treatments (while ignoring those with very few data points). Then, specific types of treatments such as diet will be ranked against each another (while including treatments with very few data points). That analysis should help you understand:
The charts section provides breakdowns for individual treatments. If a treatment has very few data points, it may be grouped together with other similar treatments.
The Symptoms versus treatment responses section analyzes whether self-reported symptoms correlate with treatment response.
The Severity analysis section looks at whether or not treatment responses are different based on peak severity (during the worst month of illness), current severity (past 30 days), and recovery (current versus peak severity).
If you're interested in a particular treatment, search this webpage for the name of that treatment. On desktops, use Crtl+F to bring up your browser's search function.
Treatment names are usually chosen to be short and memorable:
Remember to search for brand names and short versions of a treatment's name. Usually there is a section where multiple names for a single treatment are listed- searching for any of the names will help you find the shortened memorable names.
All treatments are judged based on its average score. If all surveyees were to report mild improvement, then the average score would be 1.
For risk scoring, only the negative scores are considered. The maximum possible range is from 0 to -3.
NOTE: This way of surveying patients likely measures patient satisfaction more than medical outcomes. It also measures aspects unrelated to medical outcomes (or patient satisfaction) such as how surveyees interpret survey questions, unfilled survey questions (even though the surveyee tried that treatment), etc.
Ranking of treatments surveyed.
While the chart above is limited to the most popular treatments, the tables below have data on all 235 treatments. Some of them are grouped together.
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Avacen] | 3.00 | 0.00 | 1 |
2 | [Rupatadine] | 3.00 | 0.00 | 1 |
3 | [Inuspheresis] | 2.00 | 0.00 | 2 |
4 | [Wet cupping] | 1.67 | 0.00 | 3 |
5 | [Other diet] | 1.54 | 0.00 | 56 |
6 | [Urotherapy] | 1.50 | 0.00 | 4 |
7 | [PLEX] | 1.50 | 0.00 | 2 |
8 | [Stem cells] | 1.43 | 0.00 | 7 |
9 | [Other brain retraining] | 1.38 | 0.00 | 60 |
10 | [Ayurveda] | 1.38 | -0.08 | 13 |
11 | [Photobiomodulation] | 1.36 | -0.09 | 11 |
12 | [Doxylamine] | 1.33 | 0.00 | 6 |
13 | [ASEA Redox] | 1.33 | -0.33 | 9 |
14 | [Cardio Miracle] | 1.33 | 0.00 | 6 |
15 | [Paleo diet] | 1.33 | 0.00 | 21 |
16 | [Pacing strategies] | 1.28 | -0.06 | 260 |
17 | [Prayer] | 1.25 | -0.01 | 170 |
18 | [Low histamine diet] | 1.25 | 0.00 | 218 |
19 | [Other chelation] | 1.20 | 0.00 | 15 |
20 | [Alinia] | 1.20 | 0.00 | 5 |
21 | [Chlorine dioxide] | 1.18 | 0.00 | 17 |
22 | [Glutenfree diet] | 1.16 | -0.00 | 206 |
23 | [Maraviroc] | 1.15 | 0.00 | 13 |
24 | [Wahls protocol] | 1.15 | -0.23 | 13 |
25 | [Benzodiazepines] | 1.13 | -0.12 | 154 |
26 | [IVIG, SCIG] | 1.12 | 0.00 | 16 |
27 | [AIP diet] | 1.08 | -0.11 | 38 |
28 | [HBOT <=1.5 ATA, HBOT >1.5 ATA] | 1.06 | -0.16 | 68 |
29 | [Anti inflammatory diet] | 1.06 | -0.04 | 95 |
30 | [Other antihistamines] | 1.06 | 0.00 | 34 |
31 | [Water and salt] | 1.02 | -0.02 | 294 |
32 | [HCG] | 1.00 | 0.00 | 1 |
33 | [Seldane] | 1.00 | 0.00 | 1 |
34 | [Quifenadine] | 1.00 | 0.00 | 1 |
35 | [Mizolastine] | 1.00 | 0.00 | 1 |
36 | [Monoclonals] | 1.00 | 0.00 | 14 |
37 | [EBOO] | 1.00 | 0.00 | 7 |
38 | [Rapamycin] | 1.00 | 0.00 | 4 |
39 | [Avoiding exercise] | 0.99 | -0.13 | 333 |
40 | [Opiates] | 0.97 | -0.26 | 62 |
41 | [Meditation] | 0.96 | -0.03 | 273 |
42 | [Ivermectin] | 0.95 | -0.15 | 140 |
43 | [Diazepam] | 0.93 | -0.26 | 68 |
44 | [Drinking water] | 0.92 | 0.00 | 165 |
45 | [LDN] | 0.90 | -0.26 | 156 |
46 | [Root wellness] | 0.90 | -0.10 | 10 |
47 | [Clarinex] | 0.90 | -0.19 | 21 |
48 | [HELP apheresis] | 0.88 | -0.50 | 8 |
49 | [Magnesium] | 0.86 | -0.06 | 400 |
50 | [Keto diet] | 0.86 | -0.23 | 69 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
51 | [Colchicine] | 0.85 | -0.21 | 34 |
52 | [VNS] | 0.85 | -0.09 | 118 |
53 | [Other muscle relaxers] | 0.85 | -0.21 | 71 |
54 | [Multiday wet fasting] | 0.85 | -0.24 | 46 |
55 | [Time] | 0.84 | -0.33 | 508 |
56 | [Guanfacine] | 0.83 | -0.33 | 24 |
57 | [IV vitamins] | 0.82 | -0.06 | 65 |
58 | [Serrapeptase] | 0.82 | -0.05 | 123 |
59 | [Activated charcoal] | 0.82 | -0.05 | 39 |
60 | [Other TCM] | 0.80 | -0.20 | 45 |
61 | [Osteopathy] | 0.80 | -0.33 | 46 |
62 | [TWC detox] | 0.80 | 0.00 | 10 |
63 | [Intermittent fasting] | 0.78 | -0.07 | 236 |
64 | [Carnivore diet] | 0.76 | -0.14 | 37 |
65 | [Methylene blue] | 0.76 | -0.06 | 33 |
66 | [Kangen water] | 0.75 | 0.00 | 4 |
67 | [EMDR] | 0.75 | -0.15 | 60 |
68 | [Hydroxyzine] | 0.74 | -0.20 | 50 |
69 | [Dry cupping] | 0.73 | -0.07 | 56 |
70 | [Plant based diet, Vegan diet] | 0.73 | -0.14 | 143 |
71 | [St. John's Wort] | 0.71 | -0.17 | 24 |
72 | [IV vitamin C] | 0.70 | -0.07 | 44 |
73 | [Lumbrokinase] | 0.70 | -0.04 | 57 |
74 | [Psychedelic mushrooms] | 0.69 | -0.20 | 51 |
75 | [Oil of oregano] | 0.69 | -0.06 | 62 |
76 | [NIBS] | 0.69 | -0.12 | 16 |
77 | [Beta blockers] | 0.68 | -0.36 | 149 |
78 | [Compression garments] | 0.67 | -0.09 | 177 |
79 | [Nattokinase] | 0.67 | -0.11 | 243 |
80 | [Ambien] | 0.67 | -0.33 | 33 |
81 | [Wim Hof with cold] | 0.66 | -0.18 | 61 |
82 | [Probiotics prebiotics] | 0.66 | -0.10 | 293 |
83 | [Plaquenil] | 0.66 | -0.32 | 44 |
84 | [Acupuncture] | 0.65 | -0.19 | 182 |
85 | [Cromolyn] | 0.65 | -0.30 | 23 |
86 | [IV ozone] | 0.64 | -0.16 | 25 |
87 | [Zeolite] | 0.64 | -0.05 | 44 |
88 | [DNRS] | 0.64 | -0.21 | 14 |
89 | [EDTA] | 0.62 | -0.12 | 8 |
90 | [Red light therapy] | 0.62 | -0.13 | 91 |
91 | [Cat's claw] | 0.62 | -0.12 | 24 |
92 | [Quantum healing] | 0.62 | -0.19 | 16 |
93 | [Nigella sativa oil] | 0.62 | -0.04 | 72 |
94 | [Zyrtec] | 0.61 | -0.13 | 202 |
95 | [Mestinon] | 0.61 | -0.39 | 23 |
96 | [Molnupiravir] | 0.60 | 0.00 | 5 |
97 | [Statins, Red yeast rice] | 0.59 | -0.18 | 71 |
98 | [Xyzal] | 0.59 | -0.41 | 34 |
99 | [Glutathione] | 0.59 | -0.08 | 162 |
100 | [Resveratrol] | 0.56 | -0.03 | 137 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
101 | [NAC] | 0.56 | -0.13 | 267 |
102 | [B vitamins] | 0.56 | -0.12 | 388 |
103 | [Multiday juice fasting] | 0.56 | -0.28 | 25 |
104 | [Aciclovir, Famciclovir, Valtrex, Valcyte] | 0.55 | -0.08 | 87 |
105 | [Vitamin D] | 0.54 | -0.05 | 429 |
106 | [CBT] | 0.54 | -0.10 | 156 |
107 | [Sleeping with head of bed elevated] | 0.53 | -0.12 | 148 |
108 | [Amphotericin, Canesten, Econazole, Fluconazol... | 0.53 | -0.25 | 108 |
109 | [24-48 hour fasting] | 0.53 | -0.40 | 101 |
110 | [Curcumin] | 0.52 | -0.08 | 310 |
111 | [CBD with THC] | 0.52 | -0.35 | 168 |
112 | [TRT] | 0.52 | -0.19 | 21 |
113 | [CoQ10] | 0.52 | -0.04 | 237 |
114 | [Quercetin] | 0.52 | -0.04 | 266 |
115 | [Patches] | 0.51 | -0.32 | 59 |
116 | [Homeopathy] | 0.51 | -0.23 | 77 |
117 | [Claritin] | 0.51 | -0.11 | 169 |
118 | [OMAD] | 0.51 | -0.22 | 135 |
119 | [Chiropractic] | 0.51 | -0.27 | 100 |
120 | [Nigella sativa capsules] | 0.51 | 0.00 | 67 |
121 | [Gupta program] | 0.50 | 0.00 | 14 |
122 | [CBD without THC] | 0.50 | -0.08 | 155 |
123 | [Zinc] | 0.50 | -0.06 | 297 |
124 | [Melatonin] | 0.50 | -0.18 | 262 |
125 | [Ebastine] | 0.50 | 0.00 | 2 |
126 | [Favipiravir] | 0.50 | 0.00 | 2 |
127 | [Heparin, Eliquis, Clopidogrel, Xarelto, Sulod... | 0.50 | -0.28 | 78 |
128 | [Immunoadsorption] | 0.50 | 0.00 | 2 |
129 | [Bentonite clay] | 0.49 | -0.06 | 35 |
130 | [Fish oil etc.] | 0.49 | -0.02 | 292 |
131 | [Ketotifen] | 0.48 | -0.45 | 29 |
132 | [ALA] | 0.48 | -0.05 | 132 |
133 | [Lion's mane] | 0.47 | -0.15 | 113 |
134 | [SGB] | 0.47 | 0.00 | 15 |
135 | [Vitamin C] | 0.47 | -0.04 | 351 |
136 | [K vitamins] | 0.46 | -0.09 | 160 |
137 | [Pepcid] | 0.46 | -0.23 | 173 |
138 | [Tollovid] | 0.45 | -0.18 | 11 |
139 | [Corticosteroids] | 0.45 | -0.50 | 164 |
140 | [Lavender] | 0.45 | -0.07 | 55 |
141 | [Dandelion] | 0.42 | -0.05 | 100 |
142 | [Other NSAID] | 0.42 | -0.21 | 182 |
143 | [NADH] | 0.41 | -0.13 | 93 |
144 | [Multiday dry fasting] | 0.40 | -0.73 | 15 |
145 | [Aspirin] | 0.40 | -0.11 | 249 |
146 | [DAO] | 0.36 | -0.19 | 59 |
147 | [Other pain relievers] | 0.36 | -0.33 | 61 |
148 | [Ashwagandha] | 0.35 | -0.19 | 150 |
149 | [Monolaurin] | 0.34 | -0.07 | 41 |
150 | [Multivitamin] | 0.34 | -0.07 | 247 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
151 | [Infrared sauna] | 0.34 | -0.45 | 67 |
152 | [Allegra] | 0.34 | -0.12 | 85 |
153 | [Advil] | 0.34 | -0.16 | 279 |
154 | [Wim Hof without cold] | 0.33 | -0.31 | 36 |
155 | [Vedicinals9] | 0.30 | -0.60 | 10 |
156 | [Benadryl] | 0.29 | -0.27 | 120 |
157 | [Tylenol] | 0.28 | -0.08 | 240 |
158 | [Augmented NAC] | 0.25 | -0.21 | 85 |
159 | [Acrivastine] | 0.25 | -0.29 | 51 |
160 | [Lightning process] | 0.25 | -0.75 | 4 |
161 | [Traditional sauna] | 0.24 | -0.39 | 41 |
162 | [Pine needle tea] | 0.24 | -0.12 | 66 |
163 | [Paxlovid] | 0.21 | -0.42 | 38 |
164 | [Other nicotine] | 0.21 | -0.27 | 33 |
165 | [Rife] | 0.20 | -0.53 | 15 |
166 | [Tetracyclines, Fluoroquinolones, Penicillins,... | 0.20 | -0.56 | 232 |
167 | [Abilify] | 0.15 | -0.30 | 20 |
168 | [Montekulast] | 0.14 | -0.32 | 50 |
169 | [Spermidine] | 0.14 | -0.09 | 35 |
170 | [Antiseizure] | 0.12 | -0.45 | 51 |
171 | [Nigella sativa seed] | 0.09 | -0.09 | 11 |
172 | [Gabapentin] | 0.06 | -0.55 | 113 |
173 | [Vaping] | 0.00 | -0.30 | 37 |
174 | [DTPA] | 0.00 | 0.00 | 2 |
175 | [Astemizole] | 0.00 | 0.00 | 1 |
176 | [Methotextrate, Biologic, DMARD] | -0.03 | -0.64 | 33 |
177 | [Metformin] | -0.09 | -0.41 | 32 |
178 | [Celexa, Lexapro, Fluvoxamine, Prozac, Paxil, ... | -0.16 | -0.63 | 206 |
179 | [Elavil, Doxepin, Pamelor, Clomipramine, Clomi... | -0.17 | -0.62 | 94 |
180 | [Cigarettes] | -0.18 | -0.28 | 40 |
181 | [Remeron, Seroquel, Wellbutrin] | -0.34 | -0.75 | 134 |
182 | [Biocidin] | -0.38 | -0.50 | 8 |
183 | [Light exercise] | -0.42 | -0.94 | 363 |
184 | [Cymbalta, Effexor] | -0.44 | -0.99 | 78 |
185 | [Frequency wand] | -0.62 | -1.25 | 8 |
186 | [Bilastine] | -0.67 | -1.00 | 3 |
187 | [Graded exercise therapy] | -0.76 | -1.22 | 129 |
188 | [Semprex D] | -1.50 | -1.50 | 2 |
189 | [Intense exercise] | -1.78 | -2.08 | 267 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Pacing strategies] | 1.28 | -0.06 | 260 |
2 | [Avoiding exercise] | 0.99 | -0.13 | 333 |
3 | [Light exercise] | -0.42 | -0.94 | 363 |
4 | [Graded exercise therapy] | -0.76 | -1.22 | 129 |
5 | [Intense exercise] | -1.78 | -2.08 | 267 |
Please note that the sample sizes for certain treatments are very small. As well, the data may be highly biased and may not be representative of how other people might respond to blood thinning drugs.
Tylenol (acetaminophen) is not considered to be a blood-thinning drug. It is included because it is a common alternative to other drugs on this list (Advil, Aspirin, etc.).
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [HELP apheresis] | 0.88 | -0.50 | 8 |
2 | [Clopidogrel] | 0.85 | -0.19 | 26 |
3 | [Serrapeptase] | 0.82 | -0.05 | 123 |
4 | [Lumbrokinase] | 0.70 | -0.04 | 57 |
5 | [Xarelto] | 0.67 | -0.44 | 9 |
6 | [Nattokinase] | 0.67 | -0.11 | 243 |
7 | [Heparin] | 0.47 | -0.32 | 19 |
8 | [Other NSAID] | 0.42 | -0.21 | 182 |
9 | [Aspirin] | 0.40 | -0.11 | 249 |
10 | [Advil] | 0.34 | -0.16 | 279 |
11 | [Tylenol] | 0.28 | -0.08 | 240 |
12 | [Eliquis] | 0.10 | -0.33 | 21 |
13 | [Sulodexide] | 0.00 | 0.00 | 3 |
Pacing strategies and HBOT (high ATA) are included as reference points.
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [PLEX] | 1.50 | 0.00 | 2 |
2 | [HBOT >1.5 ATA] | 1.48 | -0.12 | 33 |
3 | [Pacing strategies] | 1.28 | -0.06 | 260 |
4 | [Low histamine diet] | 1.25 | 0.00 | 218 |
5 | [Maraviroc] | 1.15 | 0.00 | 13 |
6 | [Benzodiazepines] | 1.13 | -0.12 | 154 |
7 | [IVIG] | 1.00 | 0.00 | 14 |
8 | [HELP apheresis] | 0.88 | -0.50 | 8 |
9 | [Multiday wet fasting] | 0.85 | -0.24 | 46 |
10 | [Clopidogrel] | 0.85 | -0.19 | 26 |
11 | [Serrapeptase] | 0.82 | -0.05 | 123 |
12 | [Intermittent fasting] | 0.78 | -0.07 | 236 |
13 | [Lumbrokinase] | 0.70 | -0.04 | 57 |
14 | [Xarelto] | 0.67 | -0.44 | 9 |
15 | [Nattokinase] | 0.67 | -0.11 | 243 |
16 | [HBOT <=1.5 ATA] | 0.66 | -0.20 | 35 |
17 | [Zyrtec] | 0.61 | -0.13 | 202 |
18 | [Statins, Red yeast rice] | 0.59 | -0.18 | 71 |
19 | [24-48 hour fasting] | 0.53 | -0.40 | 101 |
20 | [Quercetin] | 0.52 | -0.04 | 266 |
21 | [OMAD] | 0.51 | -0.22 | 135 |
22 | [Heparin] | 0.47 | -0.32 | 19 |
23 | [Pepcid] | 0.46 | -0.23 | 173 |
24 | [Corticosteroids] | 0.45 | -0.50 | 164 |
25 | [Other NSAID] | 0.42 | -0.21 | 182 |
26 | [Multiday dry fasting] | 0.40 | -0.73 | 15 |
27 | [Aspirin] | 0.40 | -0.11 | 249 |
28 | [Advil] | 0.34 | -0.16 | 279 |
29 | [Eliquis] | 0.10 | -0.33 | 21 |
30 | [Sulodexide] | 0.00 | 0.00 | 3 |
Excludes anti-depressants, anti-microbials, etc.
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Maraviroc] | 1.15 | 0.00 | 13 |
2 | [Opiates] | 0.97 | -0.26 | 62 |
3 | [Diazepam] | 0.93 | -0.26 | 68 |
4 | [Colchicine] | 0.85 | -0.21 | 34 |
5 | [Other muscle relaxers] | 0.85 | -0.21 | 71 |
6 | [Beta blockers] | 0.68 | -0.36 | 149 |
7 | [Statins, Red yeast rice] | 0.59 | -0.18 | 71 |
8 | [Other pain relievers] | 0.36 | -0.33 | 61 |
9 | [Abilify] | 0.15 | -0.30 | 20 |
10 | [Antiseizure] | 0.12 | -0.45 | 51 |
11 | [Gabapentin] | 0.06 | -0.55 | 113 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Celexa, Lexapro, Fluvoxamine, Prozac, Paxil, ... | -0.16 | -0.63 | 206 |
2 | [Elavil, Doxepin, Pamelor, Clomipramine] | -0.16 | -0.63 | 91 |
3 | [Remeron, Seroquel, Wellbutrin] | -0.34 | -0.75 | 134 |
4 | [Cymbalta, Effexor] | -0.44 | -0.99 | 78 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Diazepam] | 0.93 | -0.26 | 68 |
2 | [Guanfacine] | 0.83 | -0.33 | 24 |
3 | [Lexapro] | 0.26 | -0.37 | 62 |
4 | [Doxepin] | 0.19 | -0.28 | 32 |
5 | [Abilify] | 0.15 | -0.30 | 20 |
6 | [Prozac] | 0.12 | -0.49 | 41 |
7 | [Antiseizure] | 0.12 | -0.45 | 51 |
8 | [Gabapentin] | 0.06 | -0.55 | 113 |
9 | [Wellbutrin] | -0.05 | -0.49 | 55 |
10 | [Cymbalta] | -0.25 | -0.90 | 40 |
11 | [Pamelor] | -0.26 | -0.79 | 19 |
12 | [Clomipramine] | -0.33 | -0.33 | 3 |
13 | [Zoloft] | -0.38 | -0.83 | 42 |
14 | [Elavil] | -0.41 | -0.86 | 37 |
15 | [Fluvoxamine] | -0.42 | -0.77 | 26 |
16 | [Seroquel] | -0.52 | -0.86 | 44 |
17 | [Remeron] | -0.57 | -1.00 | 35 |
18 | [Vortioxetine] | -0.60 | -0.80 | 5 |
19 | [Effexor] | -0.63 | -1.08 | 38 |
20 | [Paxil] | -0.64 | -0.73 | 11 |
21 | [Celexa] | -0.84 | -1.05 | 19 |
While Quetiapine / Seroquel is often thought of as a TCA, it is also a H1 receptor antagonist. It is a dopamine, serotonin, and adrenergic antagonist, and a potent antihistamine with some anticholinergic properties.
DAO = Diamine Oxidase enzyme
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Rupatadine] | 3.00 | 0.00 | 1 |
2 | [Doxylamine] | 1.33 | 0.00 | 6 |
3 | [Other antihistamines] | 1.06 | 0.00 | 34 |
4 | [Quifenadine] | 1.00 | 0.00 | 1 |
5 | [Mizolastine] | 1.00 | 0.00 | 1 |
6 | [Seldane] | 1.00 | 0.00 | 1 |
7 | [Clarinex] | 0.90 | -0.19 | 21 |
8 | [Hydroxyzine] | 0.74 | -0.20 | 50 |
9 | [Zyrtec] | 0.61 | -0.13 | 202 |
10 | [Xyzal] | 0.59 | -0.41 | 34 |
11 | [Claritin] | 0.51 | -0.11 | 169 |
12 | [Ebastine] | 0.50 | 0.00 | 2 |
13 | [Ketotifen] | 0.48 | -0.45 | 29 |
14 | [Pepcid] | 0.46 | -0.23 | 173 |
15 | [DAO] | 0.36 | -0.19 | 59 |
16 | [Allegra] | 0.34 | -0.12 | 85 |
17 | [Benadryl] | 0.29 | -0.27 | 120 |
18 | [Acrivastine] | 0.25 | -0.29 | 51 |
19 | [Doxepin] | 0.19 | -0.28 | 32 |
20 | [Astemizole] | 0.00 | 0.00 | 1 |
21 | [Seroquel] | -0.52 | -0.86 | 44 |
22 | [Bilastine] | -0.67 | -1.00 | 3 |
23 | [Semprex D] | -1.50 | -1.50 | 2 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Low histamine diet] | 1.25 | 0.00 | 218 |
2 | [Benzodiazepines] | 1.13 | -0.12 | 154 |
3 | [Diazepam] | 0.93 | -0.26 | 68 |
4 | [LDN] | 0.90 | -0.26 | 156 |
5 | [Ambien] | 0.67 | -0.33 | 33 |
6 | [Cromolyn] | 0.65 | -0.30 | 23 |
7 | [Mestinon] | 0.61 | -0.39 | 23 |
8 | [Montekulast] | 0.14 | -0.32 | 50 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Cardio Miracle] | 1.33 | 0.00 | 6 |
2 | [Root wellness] | 0.90 | -0.10 | 10 |
3 | [Magnesium] | 0.86 | -0.06 | 400 |
4 | [TWC detox] | 0.80 | 0.00 | 10 |
5 | [St. John's Wort] | 0.71 | -0.17 | 24 |
6 | [Oil of oregano] | 0.69 | -0.06 | 62 |
7 | [Probiotics prebiotics] | 0.66 | -0.10 | 293 |
8 | [Nigella sativa oil] | 0.62 | -0.04 | 72 |
9 | [Cat's claw] | 0.62 | -0.12 | 24 |
10 | [Glutathione] | 0.59 | -0.08 | 162 |
11 | [NAC] | 0.56 | -0.13 | 267 |
12 | [B vitamins] | 0.56 | -0.12 | 388 |
13 | [Resveratrol] | 0.56 | -0.03 | 137 |
14 | [Vitamin D] | 0.54 | -0.05 | 429 |
15 | [CBD with THC] | 0.52 | -0.35 | 168 |
16 | [CoQ10] | 0.52 | -0.04 | 237 |
17 | [Curcumin] | 0.52 | -0.08 | 310 |
18 | [Quercetin] | 0.52 | -0.04 | 266 |
19 | [Nigella sativa capsules] | 0.51 | 0.00 | 67 |
20 | [CBD without THC] | 0.50 | -0.08 | 155 |
21 | [Melatonin] | 0.50 | -0.18 | 262 |
22 | [Zinc] | 0.50 | -0.06 | 297 |
23 | [Fish oil etc.] | 0.49 | -0.02 | 292 |
24 | [ALA] | 0.48 | -0.05 | 132 |
25 | [Lion's mane] | 0.47 | -0.15 | 113 |
26 | [Vitamin C] | 0.47 | -0.04 | 351 |
27 | [K vitamins] | 0.46 | -0.09 | 160 |
28 | [Lavender] | 0.45 | -0.07 | 55 |
29 | [Dandelion] | 0.42 | -0.05 | 100 |
30 | [NADH] | 0.41 | -0.13 | 93 |
31 | [Monolaurin] | 0.34 | -0.07 | 41 |
32 | [Multivitamin] | 0.34 | -0.07 | 247 |
33 | [Augmented NAC] | 0.25 | -0.21 | 85 |
34 | [Pine needle tea] | 0.24 | -0.12 | 66 |
35 | [Spermidine] | 0.14 | -0.09 | 35 |
36 | [Nigella sativa seed] | 0.09 | -0.09 | 11 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Other diet] | 1.54 | 0.00 | 56 |
2 | [Paleo diet] | 1.33 | 0.00 | 21 |
3 | [Low histamine diet] | 1.25 | 0.00 | 218 |
4 | [Glutenfree diet] | 1.16 | -0.00 | 206 |
5 | [Wahls protocol] | 1.15 | -0.23 | 13 |
6 | [AIP diet] | 1.08 | -0.11 | 38 |
7 | [Anti inflammatory diet] | 1.06 | -0.04 | 95 |
8 | [Keto diet] | 0.86 | -0.23 | 69 |
9 | [Plant based diet] | 0.78 | -0.08 | 99 |
10 | [Carnivore diet] | 0.76 | -0.14 | 37 |
11 | [Vegan diet] | 0.61 | -0.27 | 44 |
Hydroxychloroquine/Plaquenil inhibits autophagy rather than promoting it.
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Multiday wet fasting] | 0.85 | -0.24 | 46 |
2 | [Intermittent fasting] | 0.78 | -0.07 | 236 |
3 | [Plaquenil] | 0.66 | -0.32 | 44 |
4 | [Multiday juice fasting] | 0.56 | -0.28 | 25 |
5 | [Resveratrol] | 0.56 | -0.03 | 137 |
6 | [24-48 hour fasting] | 0.53 | -0.40 | 101 |
7 | [OMAD] | 0.51 | -0.22 | 135 |
8 | [Multiday dry fasting] | 0.40 | -0.73 | 15 |
9 | [Spermidine] | 0.14 | -0.09 | 35 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Avacen] | 3.00 | 0.00 | 1 |
2 | [Wet cupping] | 1.67 | 0.00 | 3 |
3 | [Urotherapy] | 1.50 | 0.00 | 4 |
4 | [Other brain retraining] | 1.38 | 0.00 | 60 |
5 | [Ayurveda] | 1.38 | -0.08 | 13 |
6 | [Photobiomodulation] | 1.36 | -0.09 | 11 |
7 | [ASEA Redox] | 1.33 | -0.33 | 9 |
8 | [Prayer] | 1.25 | -0.01 | 170 |
9 | [Chlorine dioxide] | 1.18 | 0.00 | 17 |
10 | [Meditation] | 0.96 | -0.03 | 273 |
11 | [VNS] | 0.85 | -0.09 | 118 |
12 | [Osteopathy] | 0.80 | -0.33 | 46 |
13 | [Other TCM] | 0.80 | -0.20 | 45 |
14 | [EMDR] | 0.75 | -0.15 | 60 |
15 | [Kangen water] | 0.75 | 0.00 | 4 |
16 | [Dry cupping] | 0.73 | -0.07 | 56 |
17 | [NIBS] | 0.69 | -0.12 | 16 |
18 | [Wim Hof with cold] | 0.66 | -0.18 | 61 |
19 | [Acupuncture] | 0.65 | -0.19 | 182 |
20 | [DNRS] | 0.64 | -0.21 | 14 |
21 | [Zeolite] | 0.64 | -0.05 | 44 |
22 | [Quantum healing] | 0.62 | -0.19 | 16 |
23 | [Red light therapy] | 0.62 | -0.13 | 91 |
24 | [CBT] | 0.54 | -0.10 | 156 |
25 | [Homeopathy] | 0.51 | -0.23 | 77 |
26 | [Chiropractic] | 0.51 | -0.27 | 100 |
27 | [Gupta program] | 0.50 | 0.00 | 14 |
28 | [Bentonite clay] | 0.49 | -0.06 | 35 |
29 | [Infrared sauna] | 0.34 | -0.45 | 67 |
30 | [Wim Hof without cold] | 0.33 | -0.31 | 36 |
31 | [Lightning process] | 0.25 | -0.75 | 4 |
32 | [Traditional sauna] | 0.24 | -0.39 | 41 |
33 | [Rife] | 0.20 | -0.53 | 15 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Other brain retraining] | 1.38 | 0.00 | 60 |
2 | [Prayer] | 1.25 | -0.01 | 170 |
3 | [Meditation] | 0.96 | -0.03 | 273 |
4 | [EMDR] | 0.75 | -0.15 | 60 |
5 | [Wim Hof with cold] | 0.66 | -0.18 | 61 |
6 | [Acupuncture] | 0.65 | -0.19 | 182 |
7 | [DNRS] | 0.64 | -0.21 | 14 |
8 | [CBT] | 0.54 | -0.10 | 156 |
9 | [Gupta program] | 0.50 | 0.00 | 14 |
10 | [Wim Hof without cold] | 0.33 | -0.31 | 36 |
11 | [Lightning process] | 0.25 | -0.75 | 4 |
*This survey did not ask whether methylene blue was taken via IV or swallowed into the body.
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [SCIG] | 2.00 | 0.00 | 2 |
2 | [Inuspheresis] | 2.00 | 0.00 | 2 |
3 | [PLEX] | 1.50 | 0.00 | 2 |
4 | [HBOT >1.5 ATA] | 1.48 | -0.12 | 33 |
5 | [Stem cells] | 1.43 | 0.00 | 7 |
6 | [Rapamycin] | 1.00 | 0.00 | 4 |
7 | [EBOO] | 1.00 | 0.00 | 7 |
8 | [IVIG] | 1.00 | 0.00 | 14 |
9 | [HELP apheresis] | 0.88 | -0.50 | 8 |
10 | [IV vitamins] | 0.82 | -0.06 | 65 |
11 | [Methylene blue] | 0.76 | -0.06 | 33 |
12 | [HBOT <=1.5 ATA] | 0.66 | -0.20 | 35 |
13 | [IV ozone] | 0.64 | -0.16 | 25 |
14 | [Biologic] | 0.56 | -0.33 | 9 |
15 | [Immunoadsorption] | 0.50 | 0.00 | 2 |
16 | [SGB] | 0.47 | 0.00 | 15 |
17 | [Corticosteroids] | 0.45 | -0.50 | 164 |
18 | [DMARD] | 0.17 | -0.50 | 12 |
19 | [Methotextrate] | -0.67 | -1.00 | 12 |
Chronic Lyme treatments such as HBOT, methylene blue, IV ozone, and monolaurin are included. Amphotericin, Canesten, Econazole, etc. are anti-fungals.
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [HBOT >1.5 ATA] | 1.48 | -0.12 | 33 |
2 | [Alinia] | 1.20 | 0.00 | 5 |
3 | [Monoclonals] | 1.00 | 0.00 | 14 |
4 | [Rapamycin] | 1.00 | 0.00 | 4 |
5 | [Ivermectin] | 0.95 | -0.15 | 140 |
6 | [Methylene blue] | 0.76 | -0.06 | 33 |
7 | [Oil of oregano] | 0.69 | -0.06 | 62 |
8 | [Plaquenil] | 0.66 | -0.32 | 44 |
9 | [HBOT <=1.5 ATA] | 0.66 | -0.20 | 35 |
10 | [IV ozone] | 0.64 | -0.16 | 25 |
11 | [Cat's claw] | 0.62 | -0.12 | 24 |
12 | [Nigella sativa oil] | 0.62 | -0.04 | 72 |
13 | [Molnupiravir] | 0.60 | 0.00 | 5 |
14 | [Aciclovir, Famciclovir, Valtrex, Valcyte] | 0.55 | -0.08 | 87 |
15 | [Amphotericin, Canesten, Econazole, Fluconazol... | 0.53 | -0.25 | 108 |
16 | [Nigella sativa capsules] | 0.51 | 0.00 | 67 |
17 | [Favipiravir] | 0.50 | 0.00 | 2 |
18 | [Lion's mane] | 0.47 | -0.15 | 113 |
19 | [Lavender] | 0.45 | -0.07 | 55 |
20 | [Monolaurin] | 0.34 | -0.07 | 41 |
21 | [Paxlovid] | 0.21 | -0.42 | 38 |
22 | [Tetracyclines, Fluoroquinolones, Penicillins,... | 0.20 | -0.56 | 232 |
23 | [Nigella sativa seed] | 0.09 | -0.09 | 11 |
24 | [Biocidin] | -0.38 | -0.50 | 8 |
'Antibiotic unknown type' = The surveyee doesn't know what antibiotic they took.
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Aminoglycosides] | 1.00 | 0.00 | 1 |
2 | [Metronidazole] | 1.00 | -0.38 | 13 |
3 | [Rapamycin] | 1.00 | 0.00 | 4 |
4 | [Clindamycin] | 0.82 | -0.55 | 11 |
5 | [Sulfonamides] | 0.56 | -0.44 | 9 |
6 | [Tetracyclines] | 0.39 | -0.39 | 49 |
7 | [Antibiotic unknown type] | 0.33 | -0.29 | 24 |
8 | [Cephalosporins] | 0.18 | -0.73 | 11 |
9 | [Other antibiotic] | 0.08 | -0.50 | 12 |
10 | [Penicillins] | 0.04 | -0.63 | 52 |
11 | [Fluoroquinolones] | -0.17 | -0.71 | 24 |
12 | [Macrolides] | -0.25 | -0.90 | 20 |
13 | [Nitrofurantoin] | -0.83 | -1.17 | 6 |
Surveyees may have answered in an acute COVID-19 context or outside of an acute COVID-19 context.
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Monoclonals] | 1.00 | 0.00 | 14 |
2 | [Ivermectin] | 0.95 | -0.15 | 140 |
3 | [TWC detox] | 0.80 | 0.00 | 10 |
4 | [Plaquenil] | 0.66 | -0.32 | 44 |
5 | [Molnupiravir] | 0.60 | 0.00 | 5 |
6 | [Vitamin D] | 0.54 | -0.05 | 429 |
7 | [Melatonin] | 0.50 | -0.18 | 262 |
8 | [Favipiravir] | 0.50 | 0.00 | 2 |
9 | [Tollovid] | 0.45 | -0.18 | 11 |
10 | [Vedicinals9] | 0.30 | -0.60 | 10 |
11 | [Paxlovid] | 0.21 | -0.42 | 38 |
Surveyees may have answered in an acute COVID-19 context or outside of an acute COVID-19 context.
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [HCG] | 1.00 | 0.00 | 1 |
2 | [St. John's Wort] | 0.71 | -0.17 | 24 |
3 | [TRT] | 0.52 | -0.19 | 21 |
4 | [Ashwagandha] | 0.35 | -0.19 | 150 |
5 | [Celexa, Lexapro, Fluvoxamine, Prozac, Paxil, ... | -0.16 | -0.63 | 206 |
6 | [Elavil, Doxepin, Pamelor, Clomipramine, Clomi... | -0.17 | -0.62 | 94 |
7 | [Remeron, Seroquel, Wellbutrin] | -0.34 | -0.75 | 134 |
8 | [Cymbalta, Effexor] | -0.44 | -0.99 | 78 |
Surveyees were instructed to leave answers blank if they weren't comfortable answering questions about CBD (which may be illegal in their jurisdiction).
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Psychedelic mushrooms] | 0.69 | -0.20 | 51 |
2 | [CBD with THC] | 0.52 | -0.35 | 168 |
3 | [Patches] | 0.51 | -0.32 | 59 |
4 | [CBD without THC] | 0.50 | -0.08 | 155 |
5 | [Other nicotine] | 0.21 | -0.27 | 33 |
6 | [Vaping] | 0.00 | -0.30 | 37 |
7 | [Cigarettes] | -0.18 | -0.28 | 40 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Other chelation] | 1.20 | 0.00 | 15 |
2 | [Activated charcoal] | 0.82 | -0.05 | 39 |
3 | [EDTA] | 0.62 | -0.12 | 8 |
4 | [DTPA] | 0.00 | 0.00 | 2 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Water and salt] | 1.02 | -0.02 | 294 |
2 | [Drinking water] | 0.92 | 0.00 | 165 |
3 | [Guanfacine] | 0.83 | -0.33 | 24 |
4 | [Beta blockers] | 0.68 | -0.36 | 149 |
5 | [Compression garments] | 0.67 | -0.09 | 177 |
6 | [Sleeping with head of bed elevated] | 0.53 | -0.12 | 148 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Ivermectin] | 0.95 | -0.15 | 140 |
2 | [Magnesium] | 0.86 | -0.06 | 400 |
3 | [TWC detox] | 0.80 | 0.00 | 10 |
4 | [Plaquenil] | 0.66 | -0.32 | 44 |
5 | [Nigella sativa oil] | 0.62 | -0.04 | 72 |
6 | [NAC] | 0.56 | -0.13 | 267 |
7 | [Vitamin D] | 0.54 | -0.05 | 429 |
8 | [Quercetin] | 0.52 | -0.04 | 266 |
9 | [Curcumin] | 0.52 | -0.08 | 310 |
10 | [Nigella sativa capsules] | 0.51 | 0.00 | 67 |
11 | [Zinc] | 0.50 | -0.06 | 297 |
12 | [Vitamin C] | 0.47 | -0.04 | 351 |
13 | [Vedicinals9] | 0.30 | -0.60 | 10 |
14 | [Augmented NAC] | 0.25 | -0.21 | 85 |
15 | [Nigella sativa seed] | 0.09 | -0.09 | 11 |
Treatments with more than 0 data points | Score | Risk score | # of data points (out of 573 surveyees) | |
---|---|---|---|---|
1 | [Avacen] | 3.00 | 0.00 | 1 |
2 | [Urotherapy] | 1.50 | 0.00 | 4 |
3 | [ASEA Redox] | 1.33 | -0.33 | 9 |
4 | [Cardio Miracle] | 1.33 | 0.00 | 6 |
5 | [Chlorine dioxide] | 1.18 | 0.00 | 17 |
6 | [Root wellness] | 0.90 | -0.10 | 10 |
7 | [TWC detox] | 0.80 | 0.00 | 10 |
8 | [Kangen water] | 0.75 | 0.00 | 4 |
9 | [Zeolite] | 0.64 | -0.05 | 44 |
10 | [DNRS] | 0.64 | -0.21 | 14 |
11 | [Gupta program] | 0.50 | 0.00 | 14 |
12 | [Lightning process] | 0.25 | -0.75 | 4 |
13 | [Augmented NAC] | 0.25 | -0.21 | 85 |
14 | [Frequency wand] | -0.62 | -1.25 | 8 |
These charts show how surveyees reported their experiences with particular treatments. If the treatment had very few data points, they are usually grouped together with other similar treatments to provide combined data.
===Popularity stats=== PostVac 4.5% 14/312 patients LC 4.3% 10/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 7.4% 23/312 patients LC 5.1% 12/235 patients MECFS 19.2% 5/26 patients
===Popularity stats=== PostVac 7.1% 22/312 patients LC 3.0% 7/235 patients MECFS 34.6% 9/26 patients
===Popularity stats=== PostVac 7.4% 23/312 patients LC 3.4% 8/235 patients MECFS 23.1% 6/26 patients
===Popularity stats=== PostVac 6.1% 19/312 patients LC 5.1% 12/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 4.2% 13/312 patients LC 9.4% 22/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 10.6% 33/312 patients LC 3.8% 9/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 7.4% 23/312 patients LC 11.9% 28/235 patients MECFS 15.4% 4/26 patients
===Popularity stats=== PostVac 1.3% 4/312 patients LC 5.5% 13/235 patients MECFS 11.5% 3/26 patients
===Popularity stats=== PostVac 38.8% 121/312 patients LC 45.1% 106/235 patients MECFS 50.0% 13/26 patients
===Popularity stats=== PostVac 43.3% 135/312 patients LC 43.4% 102/235 patients MECFS 46.2% 12/26 patients
===Popularity stats=== PostVac 45.8% 143/312 patients LC 52.3% 123/235 patients MECFS 50.0% 13/26 patients
===Popularity stats=== PostVac 32.7% 102/312 patients LC 30.6% 72/235 patients MECFS 30.8% 8/26 patients
Heparin, Eliquis / Apixiban, Clopidogrel, Xarelto, Sulodexide
===Popularity stats=== PostVac 3.2% 10/312 patients LC 2.6% 6/235 patients MECFS 11.5% 3/26 patients
===Popularity stats=== PostVac 3.5% 11/312 patients LC 3.8% 9/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 5.1% 16/312 patients LC 3.8% 9/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 45.8% 143/312 patients LC 38.3% 90/235 patients MECFS 38.5% 10/26 patients
===Popularity stats=== PostVac 20.5% 64/312 patients LC 23.0% 54/235 patients MECFS 19.2% 5/26 patients
===Popularity stats=== PostVac 10.9% 34/312 patients LC 8.9% 21/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 0.0% 0/312 patients LC 0.4% 1/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 2.9% 9/312 patients LC 4.7% 11/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 3.8% 12/312 patients LC 0.4% 1/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 0.6% 2/312 patients LC 0.0% 0/235 patients MECFS 0.0% 0/26 patients
Data on PLEX is also available from the Risk Factors Survey:
===Popularity stats=== PostVac 0.6% 2/312 patients LC 0.0% 0/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 1.3% 4/312 patients LC 1.7% 4/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 0.0% 0/312 patients LC 0.9% 2/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 0.6% 2/312 patients LC 0.0% 0/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 5.8% 18/312 patients LC 1.3% 3/235 patients MECFS 15.4% 4/26 patients
===Popularity stats=== PostVac 2.2% 7/312 patients LC 3.4% 8/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 1.3% 4/312 patients LC 0.9% 2/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 13.5% 42/312 patients LC 7.2% 17/235 patients MECFS 23.1% 6/26 patients
===Popularity stats=== PostVac 8.7% 27/312 patients LC 5.1% 12/235 patients MECFS 19.2% 5/26 patients
===Popularity stats=== PostVac 1.6% 5/312 patients LC 0.4% 1/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 9.0% 28/312 patients LC 1.7% 4/235 patients MECFS 3.8% 1/26 patients
HBOT <=1.5 ATA, HBOT >1.5 ATA
===Popularity stats=== PostVac 7.1% 22/312 patients LC 4.3% 10/235 patients MECFS 11.5% 3/26 patients
===Popularity stats=== PostVac 5.8% 18/312 patients LC 5.1% 12/235 patients MECFS 11.5% 3/26 patients
===Popularity stats=== PostVac 7.4% 23/312 patients LC 4.3% 10/235 patients MECFS 23.1% 6/26 patients
===Popularity stats=== PostVac 1.9% 6/312 patients LC 0.0% 0/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 0.6% 2/312 patients LC 0.0% 0/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 3.8% 12/312 patients LC 0.4% 1/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 24.7% 77/312 patients LC 40.0% 94/235 patients MECFS 23.1% 6/26 patients
Note: surveyees may have misinterpreted the survey question ('Increased intake of water and salt'), use the data with caution. The higher popularity of this intervention suggests that people without POTS or dysautonomia answered this question and have a different interpretation as to what this intervention is.
===Popularity stats=== PostVac 45.2% 141/312 patients LC 61.7% 145/235 patients MECFS 30.8% 8/26 patients
===Popularity stats=== PostVac 21.2% 66/312 patients LC 39.1% 92/235 patients MECFS 26.9% 7/26 patients
===Popularity stats=== PostVac 25.6% 80/312 patients LC 26.0% 61/235 patients MECFS 26.9% 7/26 patients
===Popularity stats=== PostVac 34.9% 109/312 patients LC 20.4% 48/235 patients MECFS 26.9% 7/26 patients
Do people with lower severity respond better to corticosteroids? Current severity 4 or less | Average (mean) score: 0.71 | n = 55 Current severity 5 or more | Average (mean) score: 0.28 | n = 83
===Popularity stats=== PostVac 2.9% 9/312 patients LC 1.3% 3/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 2.2% 7/312 patients LC 0.9% 2/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 1.9% 6/312 patients LC 2.6% 6/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 33.0% 103/312 patients LC 11.9% 28/235 patients MECFS 34.6% 9/26 patients
===Popularity stats=== PostVac 10.3% 32/312 patients LC 3.4% 8/235 patients MECFS 15.4% 4/26 patients
===Popularity stats=== PostVac 1.0% 3/312 patients LC 0.0% 0/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 0.0% 0/312 patients LC 0.9% 2/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 7.4% 23/312 patients LC 10.2% 24/235 patients MECFS 15.4% 4/26 patients
===Popularity stats=== PostVac 0.3% 1/312 patients LC 0.4% 1/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 4.8% 15/312 patients LC 4.7% 11/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 0.6% 2/312 patients LC 1.3% 3/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 3.8% 12/312 patients LC 10.6% 25/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 0.6% 2/312 patients LC 1.3% 3/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 3.2% 10/312 patients LC 1.3% 3/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 0.3% 1/312 patients LC 4.3% 10/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 1.9% 6/312 patients LC 1.7% 4/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 12.8% 40/312 patients LC 6.0% 14/235 patients MECFS 30.8% 8/26 patients
===Popularity stats=== PostVac 13.1% 41/312 patients LC 7.2% 17/235 patients MECFS 11.5% 3/26 patients
===Popularity stats=== PostVac 22.4% 70/312 patients LC 15.3% 36/235 patients MECFS 26.9% 7/26 patients
===Popularity stats=== PostVac 26.9% 84/312 patients LC 26.0% 61/235 patients MECFS 34.6% 9/26 patients
===Popularity stats=== PostVac 4.2% 13/312 patients LC 5.5% 13/235 patients MECFS 26.9% 7/26 patients
===Popularity stats=== PostVac 13.8% 43/312 patients LC 8.5% 20/235 patients MECFS 19.2% 5/26 patients
===Popularity stats=== PostVac 12.5% 39/312 patients LC 11.1% 26/235 patients MECFS 23.1% 6/26 patients
===Popularity stats=== PostVac 8.3% 26/312 patients LC 9.4% 22/235 patients MECFS 11.5% 3/26 patients
===Popularity stats=== PostVac 25.0% 78/312 patients LC 27.2% 64/235 patients MECFS 26.9% 7/26 patients
===Popularity stats=== PostVac 1.9% 6/312 patients LC 7.7% 18/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 2.9% 9/312 patients LC 5.5% 13/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 8.0% 25/312 patients LC 8.9% 21/235 patients MECFS 15.4% 4/26 patients
===Popularity stats=== PostVac 7.7% 24/312 patients LC 3.4% 8/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 3.8% 12/312 patients LC 8.1% 19/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 2.6% 8/312 patients LC 2.1% 5/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 9.9% 31/312 patients LC 8.5% 20/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 30.1% 94/312 patients LC 42.6% 100/235 patients MECFS 30.8% 8/26 patients
===Popularity stats=== PostVac 16.7% 52/312 patients LC 26.8% 63/235 patients MECFS 19.2% 5/26 patients
===Popularity stats=== PostVac 29.5% 92/312 patients LC 31.9% 75/235 patients MECFS 23.1% 6/26 patients
===Popularity stats=== PostVac 12.2% 38/312 patients LC 19.1% 45/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 25.0% 78/312 patients LC 37.0% 87/235 patients MECFS 15.4% 4/26 patients
===Popularity stats=== PostVac 4.8% 15/312 patients LC 5.1% 12/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 3.8% 12/312 patients LC 8.9% 21/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 8.3% 26/312 patients LC 13.2% 31/235 patients MECFS 7.7% 2/26 patients
Note: Some anti-histamine drugs (e.g. Doxepin, Seroquel) are listed under anti-depressants above.
===Popularity stats=== PostVac 3.8% 12/312 patients LC 3.8% 9/235 patients MECFS 0.0% 0/26 patients
===Popularity stats=== PostVac 4.2% 13/312 patients LC 3.4% 8/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 24.0% 75/312 patients LC 30.6% 72/235 patients MECFS 34.6% 9/26 patients
===Popularity stats=== PostVac 15.4% 48/312 patients LC 8.1% 19/235 patients MECFS 19.2% 5/26 patients
===Popularity stats=== PostVac 15.1% 47/312 patients LC 6.4% 15/235 patients MECFS 19.2% 5/26 patients
===Popularity stats=== PostVac 1.9% 6/312 patients LC 1.7% 4/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 24.0% 75/312 patients LC 20.0% 47/235 patients MECFS 38.5% 10/26 patients
===Popularity stats=== PostVac 26.9% 84/312 patients LC 26.0% 61/235 patients MECFS 19.2% 5/26 patients
===Popularity stats=== PostVac 1.3% 4/312 patients LC 1.3% 3/235 patients MECFS 3.8% 1/26 patients
===Popularity stats=== PostVac 3.8% 12/312 patients LC 3.8% 9/235 patients MECFS 11.5% 3/26 patients
===Popularity stats=== PostVac 25.3% 79/312 patients LC 28.5% 67/235 patients MECFS 34.6% 9/26 patients
===Popularity stats=== PostVac 30.8% 96/312 patients LC 27.7% 65/235 patients MECFS 26.9% 7/26 patients
===Popularity stats=== PostVac 36.5% 114/312 patients LC 44.7% 105/235 patients MECFS 69.2% 18/26 patients
===Popularity stats=== PostVac 55.8% 174/312 patients LC 51.9% 122/235 patients MECFS 53.8% 14/26 patients
===Popularity stats=== PostVac 19.6% 61/312 patients LC 13.2% 31/235 patients MECFS 30.8% 8/26 patients
===Popularity stats=== PostVac 48.7% 152/312 patients LC 52.3% 123/235 patients MECFS 65.4% 17/26 patients
===Popularity stats=== PostVac 34.6% 108/312 patients LC 19.1% 45/235 patients MECFS 34.6% 9/26 patients
===Popularity stats=== PostVac 11.2% 35/312 patients LC 7.7% 18/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 20.5% 64/312 patients LC 19.6% 46/235 patients MECFS 11.5% 3/26 patients
===Popularity stats=== PostVac 44.2% 138/312 patients LC 47.7% 112/235 patients MECFS 46.2% 12/26 patients
===Popularity stats=== PostVac 7.1% 22/312 patients LC 6.8% 16/235 patients MECFS 11.5% 3/26 patients
===Popularity stats=== PostVac 49.0% 153/312 patients LC 44.3% 104/235 patients MECFS 38.5% 10/26 patients
===Popularity stats=== PostVac 16.0% 50/312 patients LC 12.8% 30/235 patients MECFS 19.2% 5/26 patients
===Popularity stats=== PostVac 14.4% 45/312 patients LC 17.4% 41/235 patients MECFS 26.9% 7/26 patients
===Popularity stats=== PostVac 11.2% 35/312 patients LC 10.6% 25/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 18.6% 58/312 patients LC 2.6% 6/235 patients MECFS 7.7% 2/26 patients
===Popularity stats=== PostVac 45.5% 142/312 patients LC 56.6% 133/235 patients MECFS 69.2% 18/26 patients
===Popularity stats=== PostVac 52.2% 163/312 patients LC 38.7% 91/235 patients MECFS 46.2% 12/26 patients